โUrinary Succinate 2.36 (Suboptimal; optimal 0.03-2.68) - Complex II strain, consistent with NAD+ depletion from B3 0.62 ยตg/L (Suboptimal).
C. Thyroid Dysfunction Amplifies Metabolic Inefficiency
โTSH 8.72 mIU/L (High Risk; optimal 1.88-3.41) with T4 6.26 ยตg/dL (Optimal but at floor) - the thyroid is being driven maximally but producing minimally adequate hormone.
โThyroid regulates mitochondrial biogenesis, fat oxidation rate, and lipid clearance - its underperformance multiplies insulin resistance effects.
D. Lipid Dysfunction Reflects Metabolic Origin
โHDL 40 mg/dL (Suboptimal; optimal 50-90) and Apo-A1 109 mg/dL (Suboptimal; optimal 150-210) - anti-atherogenic lipid transport suppressed.
โProgression to frank insulin resistance (HOMA-IR >2.5)
โFasting glucose rising above 100 mg/dL
โHbA1c crossing into pre-diabetic range (>5.7%)
โNAFLD development - SGPT 26.3 already showing early signal
What this means for you
Your body has largely lost the ability to switch between sugar and fat as fuel - a pattern called metabolic inflexibility. Your thyroid is being pushed very hard but producing minimal output, compounding insulin resistance and slowing every downstream process. At 32, with both parents having T2DM, you are at the critical intervention window where targeted changes carry the highest return.
๐Cross-System Connectionsโ this system's state directly compounds the following